The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Azopt Eye Drops

Novartis Europharm LimitedEU/1/00/129/001

Main Information

Trade NameAzopt Eye Drops
Active SubstancesBrinzolamide
Dosage FormEye drops, suspension
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/00/129/001

Group Information

ATC CodeS01EC Carbonic anhydrase inhibitors
S01EC04 brinzolamide


License statusAuthorised
Licence Issued09/03/2000
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back